Medsafe is inviting submissions on the proposed rules (secondary legislation) and accompanying guidelines for the new "consent by verification" pathway for medicine approvals in New Zealand.
The new expedited verification pathway, introduced under the Medicines Amendment Act 2025, enables Medsafe to approve medicines that have already been assessed and approved by two recognised overseas regulators. For more information about the new approvals pathway, see our previous update.
The consultation is primarily aimed at pharmaceutical companies seeking to submit applications via this verification pathway.
Submissions must be made via the official consultation website by 10 April 2026.
If you have any questions, please contact one of our health team.
Co-authored by Aksheen Dhillon (Solicitor).
